TFO Wealth Partners LLC Purchases 1,684 Shares of DaVita Inc. (NYSE:DVA)

TFO Wealth Partners LLC lifted its position in shares of DaVita Inc. (NYSE:DVAFree Report) by 56,133.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,687 shares of the company’s stock after purchasing an additional 1,684 shares during the quarter. TFO Wealth Partners LLC’s holdings in DaVita were worth $177,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in DVA. Victory Capital Management Inc. boosted its position in shares of DaVita by 471.6% during the third quarter. Victory Capital Management Inc. now owns 34,866 shares of the company’s stock worth $3,296,000 after purchasing an additional 28,766 shares in the last quarter. Metis Global Partners LLC lifted its position in DaVita by 17.9% in the 3rd quarter. Metis Global Partners LLC now owns 4,094 shares of the company’s stock valued at $387,000 after acquiring an additional 623 shares in the last quarter. New York Life Investment Management LLC lifted its position in DaVita by 28.1% in the 3rd quarter. New York Life Investment Management LLC now owns 13,290 shares of the company’s stock valued at $1,256,000 after acquiring an additional 2,913 shares in the last quarter. Amalgamated Bank lifted its position in DaVita by 33.0% in the 3rd quarter. Amalgamated Bank now owns 27,411 shares of the company’s stock valued at $2,591,000 after acquiring an additional 6,806 shares in the last quarter. Finally, Janney Montgomery Scott LLC lifted its position in DaVita by 17.6% in the 3rd quarter. Janney Montgomery Scott LLC now owns 6,873 shares of the company’s stock valued at $650,000 after acquiring an additional 1,031 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on DVA. TheStreet raised shares of DaVita from a “c+” rating to a “b-” rating in a research report on Wednesday, February 7th. UBS Group boosted their price objective on shares of DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, February 14th. Barclays boosted their price objective on shares of DaVita from $133.00 to $150.00 and gave the company an “equal weight” rating in a research report on Monday, May 6th. StockNews.com upgraded shares of DaVita from a “buy” rating to a “strong-buy” rating in a research note on Friday. Finally, Truist Financial lifted their price target on shares of DaVita from $135.00 to $150.00 and gave the company a “hold” rating in a research note on Wednesday, May 15th. Two analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $144.67.

View Our Latest Research Report on DaVita

Insider Transactions at DaVita

In other news, Director Barbara J. Desoer sold 5,030 shares of the business’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $138.81, for a total transaction of $698,214.30. Following the transaction, the director now directly owns 10,954 shares in the company, valued at approximately $1,520,524.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is owned by company insiders.

DaVita Stock Down 1.0 %

Shares of DVA stock opened at $145.61 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 1.37 and a debt-to-equity ratio of 7.95. DaVita Inc. has a 1 year low of $71.51 and a 1 year high of $147.93. The firm’s fifty day moving average price is $136.25 and its two-hundred day moving average price is $121.57. The firm has a market capitalization of $12.77 billion, a P/E ratio of 16.55, a PEG ratio of 1.12 and a beta of 0.96.

DaVita (NYSE:DVAGet Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.95 by $0.43. The firm had revenue of $3.07 billion for the quarter, compared to analyst estimates of $3.03 billion. DaVita had a net margin of 6.61% and a return on equity of 68.52%. The company’s revenue was up 6.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.58 EPS. On average, equities analysts predict that DaVita Inc. will post 9.62 EPS for the current fiscal year.

DaVita Company Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Articles

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVAFree Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.